Microsize Announces a Strategic Investment into The Solubility Company to Accelerate the US Expansion of a Novel, Disruptive Solubility Measuring Technology.
Summary
TJ Higley, CEO of Microsize, added: “We couldn’t be more excited to support The Solubility Company in the expansion of this powerful technology to customers stateside. While operating as a discreet and fully autonomous entity within our facilities, the synergistic value of The Solubility Company’s SPA™ technology to Microsize clients is meaningful. This partnership should further streamline, speed to market for our clients by combining early answers in solubility alongside our full suite of solid-state characterization capabilities under one roof. Adding this type characterization in parallel with our particle engineering technologies, we can unlock immense value in developing the best drug product intermediate for our clients. He further characterized the investment by leading industry experts as “a testament to The Solubility Company’s pioneering work in pharmaceutical analysis.